Calls Now Open
2027 Scholar-Innovator and ADDF-Harrington
Rare/Orphan, Oncology, Virology
A Genetically Programmed Therapeutic for Sensing and Killing ErbB4-Hyperactive Medulloblastoma
2025 Oxford-Harrington Rare Disease Scholar
Full profile coming soon.